We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The production, sale and distribution of Pravachol and generic pravastatin sodium by Bristol-Myers Squibb (BMS) and Watson Pharmaceuticals are being challenged in federal court.
The FDA is pledging to continue fighting an effort by wholesalers to stop the agency from implementing its drug-tracking rule, despite early setbacks in court.
A Beijing court has ordered the three local drug manufacturers in China to pay a $38,000 fine, apologize publicly and stop making counterfeit versions of Pfizer’s blockbuster impotence drug, Viagra, a company spokesman said.
Plaintiffs are asking the Supreme Court to review the dismissal of a case to determine the legality of reverse payment agreements, where brand drugmakers pay generic rivals to keep their low-cost
versions of prescription products off the market.
The U.S. District Court for the District of Delaware officially dropped the patent infringement litigation concerning a generic version of GlaxoSmithKline’s migraine and cluster headache drug Imitrex (sumatriptan succinate), Spectrum Pharmaceuticals announced last week.
Plaintiffs are asking the Supreme Court to review the dismissal of a case to determine the legality of reverse payment agreements, where brand drugmakers pay generic rivals to keep their low-cost versions of prescription products off the market.
With no glaring legal discrepancies in a lower court ruling that sustained the validity of Eli Lilly’s Zyprexa patent, generic firms will have to wait five years before bringing their versions of the schizophrenia treatment drug to market, a federal appeals court has ruled.
Reliant Pharmaceuticals has filed a lawsuit against Par Pharmaceutical in response to Par’s plan to market propafenone HCl capsules, a generic version of Rythmol SR extended-release capsules.
Ortho-McNeil Pharmaceutical has filed a patent infringement lawsuit to stop Barr Laboratories’ move to offer a generic version of the epilepsy and migraine drug, Topamax.